EMBL Research: Studying the relationship between cancer-promoting proteins
A new EMBL study reveals how the cancer-promoting MAGE family of proteins bind to their targets, aiding the development…
A new EMBL study reveals how the cancer-promoting MAGE family of proteins bind to their targets, aiding the development…
Springer Medizin, ein Tochterunternehmen der Wissenschaftsverlagsgruppe Springer Nature, zeichnet in diesem Jahr ern…
CELLphenomics and Charles River Laboratories International, Inc. (NYSE: CRL) announced an agreement, that provides Charl…
} PARTNERSCHAFT KOMBINIERT OWKINS FÄHIGKEITEN ZUR K.I.-GESTÜTZTEN ENTDECKUNG VON TARGETS MIT EVOTECS INTEGRIERTEN SHARE…
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advan…
More than 30 Bavarian biotech companies present medical solutions Munich is a unique ecosystem for globally successf…
The European Medicines Agency (EMA) has granted Orphan Drug Designation for resminostat for treatment of cutaneous T…
KYAN Technologies, a vanguard combinatory drug development solutions provider, is thrilled to announce a strategic partn…
Durch den Boden übertragene Infektionen mit parasitären Würmern betreffen ärmste und am stärksten benachteiligte Bevölke…
Large quantities of the protein IGF2BP2 not only make bowel cancer grow faster, but they also make it resistant to commo…